Qiu Li

5.2k total citations · 2 hit papers
169 papers, 2.3k citations indexed

About

Qiu Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Qiu Li has authored 169 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 48 papers in Oncology and 34 papers in Molecular Biology. Recurrent topics in Qiu Li's work include Gastric Cancer Management and Outcomes (23 papers), Colorectal Cancer Treatments and Studies (15 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Qiu Li is often cited by papers focused on Gastric Cancer Management and Outcomes (23 papers), Colorectal Cancer Treatments and Studies (15 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Qiu Li collaborates with scholars based in China, United States and Sweden. Qiu Li's co-authors include Hu Yang, Boxuan Li, Xin Qiao, Juan Wang, Feng Wen, Miao Liu, Yang Yang, Shuo Li, Yi Zhao and Yujiao Wang and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Qiu Li

157 papers receiving 2.3k citations

Hit Papers

Dendrimer-based drug delivery systems: history, challenge... 2022 2026 2023 2024 2022 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dendrimer-based drug delivery systems: history, challenges, and latest developments
    2022 224 citations Qiu Li et al. profile →
  2. Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
    2022 166 citations Qiu Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiu Li China 25 763 474 412 372 303 169 2.3k
Bin Sun China 31 1.1k 1.5× 707 1.5× 418 1.0× 729 2.0× 299 1.0× 94 3.0k
Rong Liang China 28 1.1k 1.5× 475 1.0× 297 0.7× 621 1.7× 135 0.4× 127 2.6k
Ana Margarida Abrantes Portugal 30 782 1.0× 613 1.3× 387 0.9× 414 1.1× 572 1.9× 165 3.1k
Xiong Chen China 19 853 1.1× 450 0.9× 667 1.6× 417 1.1× 196 0.6× 80 1.9k
Jie Xia China 31 1.7k 2.2× 325 0.7× 341 0.8× 425 1.1× 372 1.2× 147 2.9k
Zhiqiang Huang China 30 764 1.0× 344 0.7× 272 0.7× 140 0.4× 481 1.6× 140 2.4k
Rui Tang China 31 1.2k 1.6× 723 1.5× 767 1.9× 678 1.8× 342 1.1× 166 3.0k
Yuanyuan Jiang China 30 1.4k 1.8× 590 1.2× 544 1.3× 494 1.3× 180 0.6× 191 3.0k
Huan Liu China 26 691 0.9× 223 0.5× 390 0.9× 272 0.7× 209 0.7× 151 2.0k
Yao‐Ching Hung Taiwan 33 763 1.0× 428 0.9× 195 0.5× 286 0.8× 433 1.4× 100 2.6k

Countries citing papers authored by Qiu Li

Since Specialization
Citations

This map shows the geographic impact of Qiu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiu Li more than expected).

Fields of papers citing papers by Qiu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiu Li. The network helps show where Qiu Li may publish in the future.

Co-authorship network of co-authors of Qiu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qiu Li. A scholar is included among the top collaborators of Qiu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiu Li. Qiu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Rong, et al.. (2025). Three polysaccharides from Roughhaired Holly Root with immune-enhancing activity via activation of TLR receptor. International Journal of Biological Macromolecules. 308(Pt 3). 142266–142266. 1 indexed citations
2.
3.
Huang, Lan, Yanan Deng, Xinyu Zhao, et al.. (2025). SENP1-mediated deSUMOylation of YBX1 promotes colorectal cancer development through the SENP1-YBX1-AKT signaling axis. Oncogene. 44(19). 1361–1374. 2 indexed citations
4.
Wang, Yuheng, et al.. (2024). APDF: An active preference-based deep forest expert system for overall survival prediction in gastric cancer. Expert Systems with Applications. 245. 123131–123131. 3 indexed citations
5.
Liu, Xiang‐Yang, Yue Pan, Yubin Li, et al.. (2024). Electron-rich Ni3Zn strongly interacted on ZnO promoter for deep hydrogenation of phenanthrene in dibenzothiophene. Chemical Engineering Science. 299. 120404–120404. 1 indexed citations
6.
Fong, K.F., et al.. (2024). Nonexecutive employee compensation and firm labor productivity. Finance research letters. 73. 106678–106678.
7.
8.
Gong, Xiaocheng, Yunfei Liu, Keying Liang, et al.. (2024). Cucurbitacin I exerts its anticancer effects by inducing cell cycle arrest via the KAT2a-ube2C/E2F1 pathway and inhibiting HepG2-induced macrophage M2 polarization. Biochemical and Biophysical Research Communications. 738. 150508–150508. 3 indexed citations
9.
10.
Zhou, Kexun, et al.. (2024). Pathogenesis and Systemic Treatment of Hepatocellular Carcinoma: Current Status and Prospects. Molecular Cancer Therapeutics. 24(5). 692–708. 1 indexed citations
11.
Wen, Feng, et al.. (2024). Promising first‐line immuno‐combination therapies for unresectable hepatocellular carcinoma: A cost‐effectiveness analysis. Cancer Medicine. 13(16). e70094–e70094. 2 indexed citations
12.
13.
Zhao, Chenyang, Yusen Zhang, Heng Lu, et al.. (2024). Reliability and Availability of the 2017 EULAR‐OMERACT Scoring System for Ultrasound Synovitis Assessment. Journal of Ultrasound in Medicine. 44(2). 335–347. 2 indexed citations
14.
Cui, Tianlei, et al.. (2023). #6688 HEMODIALYSIS CATHETER-RELATED RIGHT ATRIAL THROMBOSIS AND PULMONARY EMBOLISM: ANTICOAGULANT THERAPY MAY NOT BE REQUIRED. Nephrology Dialysis Transplantation. 38(Supplement_1).
15.
Li, Xiaoyu, Pei Shu, Diyuan Qin, et al.. (2023). First-in-human, phase I study of KC1036, a multiple kinase inhibitor, as a single agent in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). e15000–e15000. 1 indexed citations
16.
Chen, Zhikui, et al.. (2023). Multiview Deep Forest for Overall Survival Prediction in Cancer. Computational and Mathematical Methods in Medicine. 2023(1). 7931321–7931321. 3 indexed citations
17.
Luo, Xufei, Yunlan Liu, Mengjuan Ren, et al.. (2022). Investigation and Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019: Analysis on Dissemination and Implementation. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Peng, Wei, Xiaoyun Zhang, Chuan Li, et al.. (2022). Programmed cell death protein 1 and tyrosine kinase inhibition plus transcatheter arterial chemoembolization of advanced hepatocellular carcinoma. British journal of surgery. 110(7). 746–748. 6 indexed citations
19.
Li, Qiu, Linfei Hu, Huijuan Wang, et al.. (2020). FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer. Cell Death and Disease. 11(10). 839–839. 7 indexed citations
20.
Peng, Yulan, Qiu Li, Buyun Ma, et al.. (2014). [The perfusion pattern of lymphadenopathy in contrast-enhanced ultrasonograph. under different reference conditions ].. PubMed. 45(6). 1005–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Sun Breakdown of academic impact, for papers by Rong Liang Breakdown of academic impact, for papers by Ana Margarida Abrantes Breakdown of academic impact, for papers by Xiong Chen Breakdown of academic impact, for papers by Jie Xia Breakdown of academic impact, for papers by Zhiqiang Huang Breakdown of academic impact, for papers by Rui Tang Breakdown of academic impact, for papers by Yuanyuan Jiang Breakdown of academic impact, for papers by Huan Liu Breakdown of academic impact, for papers by Yao‐Ching Hung
Rankless by CCL
2026